WOW. EUA for no efficacy and leronlimab sits on th
Post# of 148187
CONCLUSIONS
No significant differences were observed in clinical status or overall mortality between patients treated with convalescent plasma and those who received placebo. (PlasmAr ClinicalTrials.gov number, NCT04383535. opens in new tab.)
https://www.nejm.org/doi/full/10.1056/NEJMoa2031304